KIMS Reports NIL Deviation in QIP Fund Utilization for Q1 FY27
Krishna Institute of Medical Sciences Limited reported NIL deviation in QIP fund utilization for the quarter ended June 30, 2026. Total funds raised were ₹1500 crore on June 19, 2026. Utilized amount was ₹1086.49 crore for debt repayment and investments.
This is a standard regulatory filing confirming adherence to the utilization plan for funds raised via QIP, with no unexpected financial events or changes reported.
The announcement is a routine compliance filing stating no deviation in fund utilization, which is a neutral event for the company's stock.
Krishna Institute of Medical Sciences Limited (KIMS) has confirmed that there was no deviation or variation in the utilization of funds raised through Qualified Institutional Placement (QIP) for the quarter ended June 30, 2026. The total amount raised was ₹1500 crore, with ₹1086.49 crore utilized across various purposes including repayment of borrowings and investment in subsidiaries.
The statement, reviewed by the Audit Committee in their meeting on August 3, 2026, indicates that funds were allocated for repayment of outstanding borrowings (₹910 crore), investment in subsidiaries for their borrowing repayments (₹130 crore), general corporate purposes (₹44 crore), and issue expenses (₹2.49 crore). The original objects and modified objects, where applicable, show no deviation in the utilization for the reported quarter.
The company raised the funds via QIP on June 19, 2026. The monitoring agency for these funds is CARE Ratings Limited. The report clarifies that any deviation, if it were to occur, would require shareholder approval if it stemmed from a change in contract terms or objects.
What to do with a filing like this
Krishna Institute of Medical Sciences Limited filed this with the NSE as a statutory disclosure, categorised under qualified institutional placement. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Krishna Institute of Medical Sciences Limited. Read the original for the full detail.